INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2012
Total net assets |
£125.0m |
NAV per share |
225.4p |
Share price |
192.8p |
Total value of unquoted investments |
£20.0m |
Total number of portfolio companies |
70 |
Cash |
5% NAV |
Cash committed and reserved to unquoted investments |
(4)% NAV |
Portfolio companies with < 1 year of cash |
9% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Aptiv Solutions |
6.2 4.6 |
Gilead Sciences Celgene Alexion |
4.5 4.1 3.9 |
Insulet Biogen Pharmaxis |
3.8 3.6 2.9 |
Teva Biomarin |
2.6 2.5 |
|
----------- |
Total |
38.7 |
Geographical Allocation |
% |
United States & Canada |
79 |
Europe |
10 |
Israel Australia |
3 3 |
Cash |
5 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
79 |
Unquoted |
16 |
Cash |
5 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JULY 2012